beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-D-Glcp

Term ID

CHEBI:63013

Synonyms

(Gal)2 (GalNAc)1 (Glc)1
2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->3)-alpha-D-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-D-glucopyranose
beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-D-Glc
GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc
GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc~OH
globotetraose
N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-D-glucose

Definition

A linear amino tetrasaccharide consisting of D-glucose at the reducing end having an N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl moiety attached at the 4-position.

References

glygen:G24499XE
glytoucan:G24499XE
kegg.glycan:G02369
pubmed:2456994
reaxys:9466242

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-D-Glcp

Phenotype where environments contain beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-D-Glcp

Phenotype modified by environments containing beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-D-Glcp

Phenotype affecting beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-D-Glcp

Human Disease Model